Patents Assigned to Dextech Medical AB
  • MODIFIED DEXTRAN CONJUGATES COMPRISING A LYSINE-UREA-GLUTAMATE PHARMACOPHORE
    Publication number: 20190175767
    Abstract: The present invention is related to modified dextran conjugates, such as guanidine-dextran conjugates, comprising a PSMA binding tripeptide. The present invention further discloses a method for preparation of said conjugates as well as their use. The conjugate of the present invention can be used for treating or diagnosis of a disease or a condition associated with expression of prostate specific membrane antigen (PSMA).
    Type: Application
    Filed: June 19, 2017
    Publication date: June 13, 2019
    Applicant: Dextech Medical AB
    Inventors: Anders R. HOLMBERG, Sten NILSSON
  • Modified hydroxypolymer conjugates with killing effect on tumor cells
    Patent number: 8106185
    Abstract: The present invention is related to a modified hydroxypolymer conjugates preferably a guanidine-dextran conjugate having a tumor cell killing activity. The modified hydroxypolymer conjugate is used as medicine, particularly for manufacturing a medicine or tumor killing composition for treating tumors. A method for producing said hydroxypolymer conjugate and a method for killing cancer cells and treating tumors is also disclosed. The invention is also related to a method for killing tumor cells and treating tumors by administering an effective amount of the modified hydroxypolymer conjugate.
    Type: Grant
    Filed: March 6, 2008
    Date of Patent: January 31, 2012
    Assignee: Dextech Medical AB
    Inventors: Anders Holmberg, Lennart Meurling
  • MODIFIED HYDROXYPOLYMER CONJUGATES WITH BONE SEEKING AND TUMOR KILLING MOIETIES
    Publication number: 20110118207
    Abstract: The present invention is related to a modified hydroxypolymer conjugate, preferably a dextran-guanidine-biphosphonate conjugate for treating not only skeletal tumors i.e. bone metastasis, particularly bone metastasis related to hormone refractory prostate cancer HRPC and breast cancer, but also osteoporosis. A method for producing and using said hydroxypolymer conjugate is also disclosed.
    Type: Application
    Filed: April 7, 2008
    Publication date: May 19, 2011
    Applicant: DEXTECH MEDICAL AB
    Inventor: Anders Holmberg
  • MODIFIED HYDROXYPOLYMER CONJUGATES WITH KILLING EFFECT ON TUMOR CELLS
    Publication number: 20080221066
    Abstract: The present invention is related to a modified hydroxypolymer conjugates preferably a guanidine-dextran conjugate having a tumor cell killing activity. The modified hydroxypolymer conjugate is used as medicine, particularly for manufacturing a medicine or tumor killing composition for treating tumors. A method for producing said hydroxypolymer conjugate and a method for killing cancer cells and treating tumors is also disclosed. The invention is also related to a method for killing tumor cells and treating tumors by administering an effective amount of the modified hydroxypolymer conjugate.
    Type: Application
    Filed: March 6, 2008
    Publication date: September 11, 2008
    Applicant: Dextech Medical AB
    Inventors: Anders Holmberg, Lennart Meurling